Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
Type (Medication, Oxygen Therapy, and Surgery), Type (Centriacinar, Panacinar, and Others), End User (Hospitals, Homecare, Specialty Centres, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the emphysema treatment market was valued at $6.3 billion in 2022, and is estimated to reach $8.7 billion by 2032, growing at a CAGR of 3.3% from 2023 to 2032. Request Sample of the Report on Emphysema Treatment Market Forecast - https://www.alliedmarketresearch.com/request-sample/A14372 Prime Determinants of Growth The emphysema treatment market has experienced significant growth owing to rise in prevalence of emphysema cases globally. Furthermore, rise in number of smokers has contributed in the increasing prevalence of emphysema. In addition, Asia-Pacific is expected to present significant opportunities for growth owing to rise in awareness programs for emphysema, increasing diagnosis and increase in investments for well-developed health
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Ocado hit by backlash over founder's £14.8m pay deal as fifth of investors revolt [Yahoo! Finance]Yahoo! Finance
- AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown [Yahoo! Finance]Yahoo! Finance
- AstraZeneca's Fasenra: Approval for asthma may initiate COPD approval [Yahoo! Finance]Yahoo! Finance
- Ryanair's Michael O'Leary, who is up for a $108 million bonus, doesn't see high CEO pay as a problem: ‘Footballers are getting half a million a week' [Yahoo! Finance]Yahoo! Finance
- AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/29/24 - Form 6-K
- 4/29/24 - Form 6-K
- 4/25/24 - Form 6-K
- AZN's page on the SEC website